Recombinant Chlamydia MOMP Outer Membrane Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for recombinant expression of Chlamydia major outer membrane protein (MOMP) result in insoluble proteins, making them unsuitable as vaccine antigens, and a safe and effective Chlamydia vaccine remains unavailable to prevent infection or its associated pathologies.
Innovation Solution
A method for recombinant expression of Chlamydia MOMP in E. coli, involving transformation with an expression vector encoding a leader sequence for targeting MOMP to the outer membrane, followed by culturing conditions that permit expression and translocation, optimizing codon usage, and using a low or moderate strength promoter to achieve proper protein folding and surface expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If recombinant MOMP is expressed using conventional methods, then protein production is achieved, but the protein becomes insoluble and misfolded
Solution Approach 1:
The patent introduces a leader sequence as an intermediary element that directs the recombinant MOMP to the outer membrane of E. coli. This leader sequence acts as a mediator between the synthesized protein and its final destination, ensuring proper translocation and folding. The leader sequence includes specific amino acid motifs that recognize and bind to outer membrane translocation machinery, facilitating correct protein insertion and preventing misfolding that occurs in conventional cytoplasmic expression methods.
Solution Approach 2:
The patent modifies several parameters of the expression system: (1) changes the subcellular location from cytoplasm to outer membrane, (2) optimizes codon usage to match E. coli preferences for improved translation efficiency, (3) selects specific promoter strength to control expression levels, and (4) chooses appropriate growth conditions. These parameter changes collectively enable proper protein folding while maintaining production quantity.
2Manufacturing precision
If MOMP is targeted to the outer membrane using a leader sequence, then proper protein folding is achieved, but expression system complexity increases
Solution Approach 1:
The expression vector is segmented into distinct functional modules: (1) promoter region for transcription control, (2) leader sequence encoding region for targeting signals, (3) MOMP coding sequence, and (4) selectable marker. This segmentation allows each component to be independently optimized and facilitates easy modification of individual elements without affecting the entire construct, thereby managing complexity while achieving proper folding.
3Productivity
If high expression levels are achieved, then vaccine antigen quantity is sufficient, but protein solubility decreases
Solution Approach 1:
The leader sequence is designed to facilitate preliminary actions of proper protein translocation and insertion into the outer membrane before the full-length MOMP can misfold or aggregate. By establishing the correct structural context early in the expression process, high levels of soluble, properly folded protein can be achieved even at high expression rates.
Data Source
AI summary
The present invention relates to methods for the recombinant expression of chlamydia major outer membrane protein (MOMP) comprising transforming a population of E. coli host cells with an expression vector comprising a nucleic acid molecule that encodes chlamydia MOMP and encodes a leader sequence for targeting the MOMP to the outer membrane of the cell, wherein the nucleic acid molecule is operatively linked to a promoter. The method of the invention allows expression of MOMP in the outer membrane of the cell, which leads to protein folding that is more like native MOMP relative to a MOMP protein that is expressed intracellularly. Also provided by the invention are uses of the recombinant MOMP in pharmaceutical compositions and methods for the treatment and/or prophylaxis of chlamydia infection and/or the effects thereof.